發行人所發行上市權證/可轉換債券的相關信息 發行人所發行上市權證/可轉換債券 不適用 其他信息 其他信息 不適用 發行人董事 於本公告日期，本公司董事會由六名執行董事包括朱林瑤女士、林嘉宇先生、夏利群先生、潘昭國先生、林嘉炘女士及蔡文霞女 士，以及三名獨立非執行董事李祿兆先生、Jonathan Jun YAN先生及侯海濤先生組成。 第 2 頁 共 2 頁 v 1.1.1 第 1 頁 共 2 頁 v 1.1.1 EF001 EF001 免責聲明 | 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因 | | | --- | --- | | 公告全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 | | | 股票發行人現金股息公告 | | | 發行人名稱 | 華寶國際控股有限公司 | | 股份代號 | 00336 | | 多櫃檯股份代號及貨幣 | 不適用 | | 相關股份代號及名稱 | 不適用 | | 公告標題 | 截至2025年12月31日止年度之特別股息 | | 公告日期 | 2026年3月20日 | | 公告狀 ...

Financial Performance - Revenue for the year ended December 31, 2025, was RMB 3,484,655,000, an increase of 3.3% from RMB 3,373,265,000 in 2024[3] - Gross profit decreased to RMB 1,423,146,000, with a gross margin of 40.8%, down from 42.7% in the previous year[3] - Operating loss improved to RMB 360,879,000, compared to a loss of RMB 401,946,000 in 2024, resulting in an operating margin of -10.4%[3] - Net loss attributable to equity holders was RMB 388,803,000, slightly higher than RMB 385,509,000 in 2024[3] - EBITDA for the year was RMB (8,411,000), an improvement from RMB (69,690,000) in 2024, with an EBITDA margin of -0.2%[3] - Cash generated from operating activities increased to RMB 825,947,000, up from RMB 679,702,000 in the previous year[3] - The company reported a total loss for the year of RMB 405.49 million, with a pre-tax loss of RMB 286.85 million[20] - The company reported a net financial income of RMB 76,969,000, compared to RMB 55,784,000 in 2024[6] - The company’s fragrance raw materials segment reported revenue of approximately RMB 807 million, and the seasoning segment achieved revenue of approximately RMB 831 million, both showing progress in internationalization[44] Assets and Equity - Total assets decreased to RMB 14,390,291,000 from RMB 15,002,076,000 in 2024[10] - Total equity decreased to RMB 13,036,309,000 from RMB 13,720,356,000 in 2024[10] - Trade receivables as of December 31, 2025, were RMB 831,699, compared to RMB 769,875 in 2024, reflecting a rise of approximately 8%[32] - The total amount of unused raised funds is RMB 1,354.57 million, excluding interest and cash management income[1] - The group’s cash and bank deposits amounted to RMB 3,601,295,000 as of December 31, 2025, down from RMB 5,562,231,000 in the previous year[94] Dividends and Shareholder Returns - The company declared a special dividend of HKD 0.055 per share, up from HKD 0.050 per share in 2024[3] - The company proposed a special dividend of approximately RMB 160,453,000 for the year ending December 31, 2025, which is a new initiative compared to the previous year's dividend[31] - The board recommends a special dividend of HKD 0.055 per share, totaling approximately RMB 160.453 million, compared to RMB 147.998 million in 2024[128] Expenses and Costs - Total sales costs, marketing, and administrative expenses for the year ended December 31, 2025, amounted to RMB 3,485,285, an increase from RMB 3,232,865 in 2024, representing a growth of approximately 7.8%[22] - Selling and marketing expenses increased by 23.3% to RMB 456,468,000, representing approximately 13.1% of total revenue, up from 11.0% in the previous year[88] - Administrative expenses rose by 3.9% to RMB 967,308,000, maintaining a stable ratio of about 27.8% of total revenue[89] - Research and development expenses for the year ended December 31, 2025, were RMB 287,001, up from RMB 245,242 in 2024, indicating an increase of about 17%[22] Strategic Initiatives and Acquisitions - The company is focusing on new tobacco products, particularly HNB (Heat-not-burn) and smoke-free products, with a strategy for global patent layout and overseas production capacity[38] - The company completed the acquisition of Hunan Jiapin Jiwei Technology Development Group Co., Ltd. in June 2025, enhancing its capabilities in natural meat extraction and flavor innovation[39] - In August 2025, the company acquired 51% of Jiangsu Jiafu Food Co., Ltd. for approximately RMB 159 million, expanding its product offerings in the seasoning sector and improving operational efficiency[40] - The company increased its stake in Xiamen Amber, which specializes in daily fragrance R&D and production, solidifying its leadership in the domestic market for incense and disinfection products[41] Market Trends and Projections - The global tobacco industry is projected to reach approximately $520 billion in sales by 2025, with a year-on-year growth of about 3.4%[46] - The market for heated-not-burn (HNB) tobacco products is expected to reach RMB 95.867 billion by 2025, with a compound annual growth rate (CAGR) of 16.29% from 2025 to 2032[46] - The compound seasoning market is projected to reach RMB 138 billion by 2025, with a CAGR of 7% from 2024 to 2029[51] - The health and wellness market is estimated to reach RMB 769.53 billion globally by 2025, with a CAGR of 7.34% until 2032[53] Governance and Compliance - The audit committee, composed of all independent non-executive directors, has reviewed the group's audited annual performance for the year[133] - The company has adopted the standard code for securities transactions by directors, ensuring compliance throughout the year[127] - The CEO position has been separated from the chairman role, with Mr. Xia Liqun appointed as CEO effective January 7, 2026[126] - The company has complied with corporate governance codes to support long-term business development[126] Digital Transformation and AI Integration - The company invested in digital transformation, with AI applications enhancing operational efficiency, including a 95% effectiveness rate in AI optical sorting projects[45] - The establishment of the AI+ task force and the deployment of high-performance local models are expected to drive future AI applications and digital management improvements[45] - The company plans to enhance AI applications across all operations to improve efficiency and drive business growth[81] Legal and Arbitration Matters - The arbitration ruling requires QIAN RONG and Huang Jinrong to pay a total of RMB 432.02 million in performance compensation to Huabao Co., along with additional fees totaling RMB 15.39 million[121][122] - The Group has taken all feasible legal actions regarding the arbitration case, ensuring that the outcomes align with the best interests of the company and its shareholders[123]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不發 表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承 擔任何責任。 HUABAO INTERNATIONAL HOLDINGS LIMITED 華 寶 國 際 控 股 有 限 公 司 * （於百慕達註冊成立之有限公司） （股份代號：00336） 內幕消息 華寶香精股份有限公司截至 2025 年 12 月 31 日止年度之 主要會計數據和財務指標 本公告乃由華寶國際控股有限公司（「本公司」）根據香港聯合交易所有限公司證券上市規 則第13.09條刊發及香港法例第571章證券及期貨條例第XIVA部內幕消息條文而作出。 華寶香精股份有限公司（「華寶股份」）為本公司之附屬公司及其股份於深圳證券交易所創 業板上市（代碼：300741）。按深圳證券交易所之相關規定，華寶股份在2026年3月20日已將 其截至2025年12月31日止年度報告刊載於深圳證券交易所創業板信息披露網站巨潮資訊網 (http://www.cninfo.com.cn)。 本公司之董事會謹請本公司股東及公眾投資者留 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不 發表任何聲明，並明確表示概不就因本公告全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失 承擔任何責任。 HUABAO INTERNATIONAL HOLDINGS LIMITED 華 寶 國 際 控 股 有 限 公 司 * （於百慕達註冊成立之有限公司） （股份代號：00336） 附屬公司調整募投項目投資計劃進度 調整募投項目投資計劃進度 - 華寶科創中心項目及華寶數位化項目 華寶股份於2026年3月20日召開第三屆董事會第二十四次會議，審議通過了「關 於調整募投項目投資計劃進度的議案」，同意調整華寶科創中心項目及華寶數位 化項目的投資計劃進度。本議案不涉及募集資金用途變更，無需提交華寶股份股 東會審議。 華寶科創中心項目 華寶科創中心項目募集資金承諾投資總額人民幣44,997.42萬元，所需土地性質應 由工業用地變更為研發用地，自有地塊土地性質變更及相關土地收儲工作已完 成，用地手續辦理及後續事宜持續推進中，其中，自有土地補充合同及合併後的 整體土地合同，目前正由政府相關部門擬定中，土地合同的擬定與簽署進 ...

智通财经APP讯，华宝国际(00336)发布公告，于2026年3月20日该公司注销149.5万股已购回股份。 ...

表格類別： 股票 狀態： 新提交 公司名稱： 華寶國際控股有限公司（於百慕達註冊成立之有限公司） 呈交日期： 2026年3月20日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | | 是 | | | 證券代號 (如上市) | 00336 | 說明 | 華寶國際 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | 事件 | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | 每股發行/出售價 (註4) | | 已發行股份總數 | | | | 已發行股份（不包括庫存股份）數 目 | | ...

Core Viewpoint - The company, Huabao International, is a leading player in the flavor and fragrance industry in China and has strong global competitiveness, with a diversified product range and a significant overseas expansion strategy [1] Group 1: Business Performance - Huabao International has maintained its position as the top company in the flavor and fragrance industry in China for 20 consecutive years, with products including tobacco flavors, food flavors, daily-use fragrances, and composite seasonings [1] - The company's production capacity at its Indonesian base has reached 3,000 tons annually, and it has successfully supplied new reconstituted tobacco leaves to international clients [1] - The domestic tobacco flavor business is experiencing a contraction due to the "self-controllable" policy from China National Tobacco, but this has been anticipated, allowing the company to focus on overseas production and sales [1] Group 2: Growth Opportunities - The overseas sales of tobacco raw materials, particularly for products like beads and HNB (Heated Not Burned) sheets, are expected to significantly increase in the first half of 2025, driving overall revenue growth [1] - The company is reducing its reliance on major clients by expanding its non-tobacco business, with its subsidiary Huabao Co. projected to turn profitable by 2025 [1] - The company has a robust cash flow, with financial liquid assets exceeding 6 billion yuan in the first half of 2025, and operating cash flows projected at 800 million, 1 billion, and 700 million yuan for 2022-2024 [2] Group 3: Strategic Initiatives - The company announced a stock incentive plan in 2025, granting 144 mid-to-senior executives nearly 2 million stock options at a price of 3.95 HKD per share, reflecting confidence in future growth [2] - The company is strategically positioned to benefit from potential policy changes in the domestic HNB market, as it is a long-term R&D partner of China National Tobacco [2] - Huabao International's investment in Boyuan Group provides an indirect entry into the HNB brand market with its NUSO brand, which has been validated in several overseas markets [2] Group 4: Financial Projections - The company is expected to achieve net profits of -280 million, 510 million, and 810 million yuan for the years 2025-2027, with corresponding P/E ratios of 23 and 14 for 2026-2027 [3] - The company is anticipated to enter a new growth phase, moving away from reliance on a single client, with short-term growth in bead business and long-term potential in sheet business as the global HNB market expands [3]

每经AI快讯，3月19日，华宝国际(00336.HK)尾盘涨近7%，截至发稿涨6.73%，报4.44港元，成交额 3238.63万港元。 （文章来源：每日经济新闻） ...

Core Viewpoint - Huabao International (00336) has seen a significant stock price increase, rising nearly 7% to HKD 4.44, driven by positive profit forecasts from its subsidiary Huabao Co. [1] Financial Performance - Huabao Co. expects an annual net profit attributable to shareholders of HKD 65 million to HKD 95 million, marking a turnaround from previous losses [1] - The anticipated losses for 2024 are primarily due to goodwill impairment related to the flavoring segment for tobacco [1] - There is no significant risk of further goodwill impairment for Huabao Co. in 2025 [1] Business Outlook - Guolian Minsheng Securities reports that Huabao International, as a leading player in the flavor and fragrance industry, is gradually reducing its dependency on a single customer and is expected to enter a new growth phase [1] - The short-term growth of the capsule business and the long-term potential of the film business are highlighted, with expectations for continued growth aligned with the global expansion of the HNB (Heat-not-Burn) market [1] - The new food ingredient factory in Indonesia is set to cover the Southeast Asian market, while the domestic Yifang company has returned to profitability, indicating potential for sustained high growth [1] - If domestic HNB regulations are relaxed and the proprietary brand NUSO develops, it could represent a significant growth opportunity [1]

Core Viewpoint - Huabao International (00336) has seen a significant stock price increase, rising nearly 7% to HKD 4.44, with a trading volume of HKD 32.39 million, following the announcement of its subsidiary Huabao Co. (300741) expecting a net profit of HKD 65-95 million, marking a turnaround from losses [1] Group 1: Company Performance - Huabao Co. anticipates a net profit of HKD 65-95 million for the fiscal year, indicating a return to profitability year-on-year [1] - The expected losses for 2024 are primarily attributed to goodwill impairment losses related to the flavoring and tobacco flavor asset group [1] - There is no significant risk of further goodwill impairment for Huabao Co. in 2025 [1] Group 2: Market Position and Growth Potential - Guolian Minsheng Securities reports that Huabao International, as a leader in the flavor and fragrance industry, is gradually reducing its dependency on a single customer and is expected to enter a 2.0 phase of growth [1] - The short-term growth of the bead business and the long-term elasticity of the film business are anticipated to continue growing with the global expansion of the HNB (Heat-not-Burn) market [1] - The commissioning of the food ingredient factory in Indonesia is set to cover the Southeast Asian market, while the domestic Yifang company has returned to profitability, suggesting a potential for sustained high growth [1] - If domestic HNB regulations are relaxed and the proprietary brand NUSO develops, it could represent a potential incremental growth opportunity [1]